The Surgical Management of Pancreatic Cancer

Gastroenterology Clinics of North America

Volumn 41, Issue 1, 2012, Pages 211-221

  Matsuoka, Lea ^a   Selby, Rick ^a   Genyk, Yuri ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Adenocarcinoma; Cancer; Pancreas; Whipple

Indexed keywords

ARTERY RECONSTRUCTION; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER SIZE; CANCER SURVIVAL; CHRONIC PANCREATITIS; DISEASE FREE SURVIVAL; GASTRECTOMY; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; OUTCOME ASSESSMENT; PANCREAS CANCER; PANCREAS FISTULA; PANCREAS PRESERVING PANCREATICODUODENECTOMY; PANCREAS RESECTION; PANCREAS SURGERY; PANCREATICODUODENECTOMY; PORTAL VEIN; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPLENECTOMY; SURGICAL APPROACH; SURGICAL MORTALITY; SURVIVAL TIME; TREATMENT INDICATION; VEIN SURGERY;

HUMANS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY;

EID: 84857093332     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2011.12.015     Document Type: Review

References (45)

1. Neoptolemos J.P., Stocken D.D., Friess H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004, 350:1200-1210.
2. Whipple A.O., Parsons W.B., Mullins C.R. Treatment of carcinoma of the ampulla of Vater. Ann Surg 1935, 102:763-779.
3. Whipple A.O. The rationale of radical surgery for cancer of the pancreas and ampullary region. Ann Surg 1941, 114:612-615.
4. Winter J.M., Cameron J.L., Campbell K.A., et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 2006, 10:1199-1210. discussion 210-1.
5. McPhee J.T., Hill J.S., Whalen G.F., et al. Perioperative mortality for pancreatectomy: a national perspective. Ann Surg 2007, 246:246-253.
6. Kazanjian K.K., Hines O.J., Duffy J.P., et al. Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: the influence of operative blood loss. Arch Surg 2008, 143:1166-1171.
7. Grobmyer S.R., Pieracci F.M., Allen P.J., et al. Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system. J Am Coll Surg 2007, 204:356-364.
8. Bassi C., Dervenis C., Butturini G., et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005, 138:8-13.
9. Wagner M., Redaelli C., Lietz M., et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 2004, 91:586-594.
10. Butturini G., Stocken D.D., Wente M.N., et al. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg 2008, 143:75-83. discussion.
11. Verbeke C.S. Resection margins and R1 rates in pancreatic cancer-are we there yet?. Histopathology 2008, 52:787-796.
12. Esposito I., Kleeff J., Bergmann F., et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 2008, 15:1651-1660.
13. Heye T., Zausig N., Klauss M., et al. CT diagnosis of recurrence after pancreatic cancer: is there a pattern?. World J Gastroenterol 2011, 17:1126-1134.
14. Sohn T.A., Yeo C.J., Cameron J.L., et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000, 4:567-579.
15. Luft H.S., Bunker J.P., Enthoven A.C. Should operations be regionalized?. The empirical relation between surgical volume and mortality. N Engl J Med 1979, 301:1364-1369.
16. Birkmeyer J.D., Warshaw A.L., Finlayson S.R., et al. Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery 1999, 126:178-183.
17. Nathan H., Cameron J.L., Choti M.A., et al. The volume-outcomes effect in hepato-pancreato-biliary surgery: hospital versus surgeon contributions and specificity of the relationship. J Am Coll Surg 2009, 208:528-538.
18. Eppsteiner R.W., Csikesz N.G., McPhee J.T., et al. Surgeon volume impacts hospital mortality for pancreatic resection. Ann Surg 2009, 249:635-640.
19. Watson K. Carcinoma of the ampulla of Vater. Successful radical resection. Br J Surg 1944, 31:368-373.
20. Traverso L.W., Longmire W.P. Preservation of the pylorus in pancreaticoduodenectomy a follow-up evaluation. Ann Surg 1980, 192:306-310.
21. Lin P.W., Lin Y.J. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 1999, 86:603-607.
22. Tran K.T., Smeenk H.G., van Eijck C.H., et al. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 2004, 240:738-745.
23. Diener M.K., Fitzmaurice C., Schwarzer G., et al. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev 2011, 5. CD006053.
24. Lillemoe K.D., Kaushal S., Cameron J.L., et al. Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg 1999, 229:693-698. discussion 8-700.
25. Sledzianowski J.F., Duffas J.P., Muscari F., et al. Risk factors for mortality and intra-abdominal morbidity after distal pancreatectomy. Surgery 2005, 137:180-185.
26. Fahy B.N., Frey C.F., Ho H.S., et al. Morbidity, mortality, and technical factors of distal pancreatectomy. Am J Surg 2002, 183:237-241.
27. Sperti C., Pasquali C., Pedrazzoli S. Ductal adenocarcinoma of the body and tail of the pancreas. J Am Coll Surg 1997, 185:255-259.
28. Fortner J.G. Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results. Ann Surg 1984, 199:418-425.
29. Pedrazzoli S., DiCarlo V., Dionigi R., et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 1998, 228:508-517.
30. Farnell M.B., Pearson R.K., Sarr M.G., et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 2005, 138:618-628. discussion 28-30.
31. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002, 236:355-366. discussion 66-8.
32. Tseng J.F., Raut C.P., Lee J.E., et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 2004, 8:935-949. discussion 49-50.
33. Riediger H., Makowiec F., Fischer E., et al. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection. J Gastrointest Surg 2006, 10:1106-1115.
34. Harrison L.E., Klimstra D.S., Brennan M.F. Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection?. Ann Surg 1996, 224:342-347. discussion 7-9.
35. Muller S.A., Hartel M., Mehrabi A., et al. Vascular resection in pancreatic cancer surgery: survival determinants. J Gastrointest Surg 2009, 13:784-792.
36. Nakagohri T., Kinoshita T., Konishi M., et al. Survival benefits of portal vein resection for pancreatic cancer. Am J Surg 2003, 186:149-153.
37. Shibata C., Kobari M., Tsuchiya T., et al. Pancreatectomy combined with superior mesenteric-portal vein resection for adenocarcinoma in pancreas. World J Surg 2001, 25:1002-1005.
38. Al-Haddad M., Martin J.K., Nguyen J., et al. Vascular resection and reconstruction for pancreatic malignancy: a single center survival study. J Gastrointest Surg 2007, 11:1168-1174.
39. Hartel M., Niedergethmann M., Farag-Soliman M., et al. Benefit of venous resection for ductal adenocarcinoma of the pancreatic head. Eur J Surg 2002, 168:707-712.
40. Bachellier P., Nakano H., Oussoultzoglou P.D., et al. Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?. Am J Surg 2001, 182:120-129.
41. Nakao A., Takeda S., Sakai M., et al. Extended radical resection versus standard resection for pancreatic cancer: the rationale for extended radical resection. Pancreas 2004, 28:289-292.
42. Yekebas E.F., Bogoevski D., Cataldegirmen G., et al. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg 2008, 247:300-309.
43. Nakao A., Takeda S., Inoue S., et al. Indications and techniques of extended resection for pancreatic cancer. World J Surg 2006, 30:976-982. discussion 83-4.
44. Takahashi S., Ogata Y., Tsuzuki T. Combined resection of the pancreas and portal vein for pancreatic cancer. Br J Surg 1994, 81:1190-1193.
45. Stitzenberg K.B., Watson J.C., Roberts A., et al. Survival after pancreatectomy with major arterial resection and reconstruction. Ann Surg Oncol 2008, 15:1399-1406.